Acute Skin Toxicity Following Stereotactic Body Radiation Therapy for Stage I Non-Small-Cell Lung Cancer: Who's at Risk?

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1283-1286

  Hoppe, Bradford S ^a   Laser, Benjamin ^a   Kowalski, Alex V ^a   Fontenla, Sandra C ^a   Pena Greenberg, Elizabeth ^a   Yorke, Ellen D ^a   Lovelock, D Michael ^a   Hunt, Margie A ^a   Rosenzweig, Kenneth E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Image guided radiation therapy; Intensity modulated radiation therapy; Lung cancer; Skin toxicity; Stereotactic body radiation therapy

Indexed keywords

BIOLOGICAL ORGANS; PATIENT MONITORING; PHYSICAL THERAPY; RADIOTHERAPY; RATE CONSTANTS; TERMINOLOGY; TOXICITY;

IMAGE-GUIDED RADIATION THERAPY; INTENSITY-MODULATED RADIATION THERAPY; LUNG CANCER; SKIN TOXICITY; STEREOTACTIC BODY RADIATION THERAPY;

SKIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COLLIMATOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; SKIN TOXICITY; STEREOTACTIC TREATMENT; WHOLE BODY AUTORADIOGRAPHY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NECROSIS; NEOPLASM STAGING; PATIENT CARE PLANNING; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SKIN;

EID: 56349111938     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.036     Document Type: Article

References (12)

1. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45 (2006) 787-795
2. Fritz P., Kraus H.J., Blaschke T., et al. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. Lung Cancer 60 (2008) 193-199
3. Lagerwaard F.J., Haasbeek C.J., Smit E.F., et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70 (2008) 685-692
4. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for Stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2 (2007) S94-S100
5. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
6. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
7. Lovelock D.M., Hua C., Wang P., et al. Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. Med Phys 32 (2005) 2606-2614
8. Spirou S.V., and Chui C.S. A gradient inverse planning algorithm with dose-volume constraints. Med Phys 25 (1998) 321-333
9. Mohan R., Barest G., Brewster L.J., et al. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys 15 (1988) 481-495
10. Liu R., Buatti J.M., Howes T.L., et al. Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions. Int J Radiat Oncol Biol Phys 66 (2006) 906-912
11. Johnson M.W., Griggs M.A., and Sharma S.C. A comparison of surface doses for two immobilizing systems. Med Dosim 20 (1995) 191-194
12. Mellenberg D.E. Dose behind various immobilization and beam-modifying devices. Int J Radiat Oncol Biol Phys 32 (1995) 1193-1197